IASIS Pharma

IASIS Pharma is a prominent Greek pharmaceutical company dedicated to the development, production, and distribution of high-quality generic and value-added medicines. Founded in 1985, the company has established a strong presence in the respiratory therapeutic area, offering advanced inhalation devices such as dry powder inhalers (DPI) and pressurized metered-dose inhalers (pMDI). Its diverse portfolio also includes significant offerings in anti-infectives, central nervous system, cardiovascular, and gastrointestinal treatments. IASIS Pharma operates state-of-the-art manufacturing facilities that comply with international Good Manufacturing Practice (GMP) standards, supporting its expansion into international markets. The company is recognized for its integrated approach, combining robust R&D capabilities with efficient manufacturing and a comprehensive sales network.